AMG-335

talquetamab · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG-335, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: AMG 335 Expanded Access Program for IgG4-Related Disease